Mutations in a new cytochrome P450 gene in lamellar ichthyosis type 3

被引:152
|
作者
Lefèvre, C
Bouadjar, B
Ferrand, V
Tadini, G
Mégarbané, A
Lathrop, M
Prud'homme, JF
Fischer, J [1 ]
机构
[1] Ctr Natl Genotypage, Evry, France
[2] Genethon, Evry, France
[3] CHU Bab El Oued, Dept Dermatol, Algiers, Algeria
[4] IRCCS, Osped Maggiore Policlin, Inst Dermatol Sci, Ctr Inherited Cutaneous Dis, Milan, Italy
[5] St Josephs Univ, Fac Med, Dept Med Genet, Beirut, Lebanon
关键词
D O I
10.1093/hmg/ddi491
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We report the identification of mutations in a non-syndromic autosomal recessive congenital ichthyosis (ARCI) in a new gene mapping within a previously identified locus on chromosome 19p12-q12, which has been defined as LI3 in the OMIM database (MIM 604777). The phenotype usually presents as lamellar ichthyosis and hyperlinearity of palms and soles. Seven homozygous mutations including five missense mutations and two deletions were identified in a new gene, FLJ39501, on chromosome 19p12 in 21 patients from 12 consanguineous families from Algeria, France, Italy and Lebanon. FLJ39501 encodes a protein which was found to be a cytochrome P450, family 4, subfamily F, polypeptide 2 homolog of the leukotriene B4-omega-hydroxylase (CYP4F2) and could catalyze the 20-hydroxylation of trioxilin A3 from the 12(R)-lipoxygenase pathway. Further oxidation of this substrate by the fatty alcohol:nicotinamide-adenine dinucleotide oxidoreductase (FAO) enzyme complex, in which one component, ALDH3A2, is known to be mutated in Sjogren-Larsson syndrome (characterized by ichthyosis and spastic paraplegia), would lead to 20-carboxy-(R)-trioxilin A3. This compound could be involved in skin hydration and would be the essential missing product in most forms of ARCI. Its chiral homolog, 20-carboxy-(S)-trioxilin A3, could be implicated in spastic paraplegia and in the maintenance of neuronal integrity.
引用
收藏
页码:767 / 776
页数:10
相关论文
共 50 条
  • [1] A cytochrome P450 gene cluster in the Rhizobiaceae
    Keister, DL
    Tully, RE
    van Berkum, P
    JOURNAL OF GENERAL AND APPLIED MICROBIOLOGY, 1999, 45 (06): : 301 - 303
  • [2] Cytochrome P450 gene polymorphism and cancer
    Agúndez, JAG
    CURRENT DRUG METABOLISM, 2004, 5 (03) : 211 - 224
  • [3] CYTOCHROME P450 GENE-REGULATION
    HANKINSON, O
    KEMPER, B
    DNA-A JOURNAL OF MOLECULAR & CELLULAR BIOLOGY, 1987, 6 (06): : 515 - 517
  • [4] Gene regulation of cytochrome P450 - An overview
    Ramana, Kota V.
    Kohli, Krishan K.
    Indian Journal of Experimental Biology, 1998, 36 (05): : 437 - 446
  • [5] Measurement of cytochrome P450 and NADPH–cytochrome P450 reductase
    F Peter Guengerich
    Martha V Martin
    Christal D Sohl
    Qian Cheng
    Nature Protocols, 2009, 4 : 1245 - 1251
  • [6] TYPE P450 CYTOCHROME IN ARUM SPADICES
    YAHIEL, V
    COTTEMAR.MG
    DUCET, G
    PHYTOCHEMISTRY, 1974, 13 (09) : 1649 - 1651
  • [7] Cytochrome P450
    P. H. Roos
    N. Jakubowski
    Analytical and Bioanalytical Chemistry, 2008, 392 : 1015 - 1017
  • [8] Cytochrome P450
    Roos, P. H.
    Jakubowski, N.
    ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2008, 392 (06) : 1015 - 1017
  • [9] Cytochrome P450
    Poulos, TL
    CURRENT OPINION IN STRUCTURAL BIOLOGY, 1995, 5 (06) : 767 - 774
  • [10] New aspects of cytochrome P450 research
    Ingelman-Sundberg, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 361 - 361